Enhancement of TFEB activity is shown to promote protein clearance and neuroprotection in PD animal models, which makes it a promising therapeutic target (Decressac and Bjorklund, 2013; Sardiello, 2016). This evidence concerns the gene TFEB and Parkinson disease.